# A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers

> **NCT02406989** · PHASE1 · COMPLETED · sponsor: **MingSight Pharmaceuticals Pty Limited** · enrollment: 32 (actual)

## Conditions studied

- Safety and PK in Healthy Volunteers

## Interventions

- **DRUG:** MS-553
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02406989
- **Lead sponsor:** MingSight Pharmaceuticals Pty Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406989, "A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02406989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*